CARPENTER CHRISTOPHER L.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2019-09-18	2019-09-17	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	41,058 +25.0% 226.13 US$3,116,864	41,058 +25.0%	226.13	US$3,116,864
2019-09-18	2019-09-16	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	19,228 +31.6% 368.68 US$1,587,997	19,228 +31.6%	368.68	US$1,587,997
2019-06-24	2019-06-20	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	16,513 -14.4% 84.36 US$2,047,736	16,513 -14.4%	84.36	US$2,047,736
2019-06-19	2019-06-19	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	18,399 -34.6% 13.80 US$253,868	18,399 -34.6%	13.80	US$253,868
2019-06-19	2019-06-18	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	10,858 -23.8% 14.27 US$154,958	10,858 -23.8%	14.27	US$154,958
2019-06-19	2019-06-17	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	18,500 -34.7% 14.10 US$260,868	18,500 -34.7%	14.10	US$260,868
2019-03-19	2019-03-15	Rubius Therapeutics Inc (RUBY)	PlS Planned sale	48,000 -57.9% 15.84 US$760,114	48,000 -57.9%	15.84	US$760,114